非酒精性脂肪性肝病与慢性阻塞性肺疾病：是时候跨越膈肌了吗？ - Suppr

Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm?

作者信息

Lonardo Amedeo, Nascimbeni Fabio, Ponz de Leon Maurizio

机构信息

Operating Unit of Internal Medicine, OCSAE, Modena, Italy

Operating Unit of Internal Medicine, OCSAE, Modena, Italy.

出版信息

Eur Respir J. 2017 Jun 8;49(6). doi: 10.1183/13993003.00546-2017. Print 2017 Jun.

DOI:10.1183/13993003.00546-2017

PMID:28596428

Abstract

摘要

相似文献

Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm?

Eur Respir J. 2017 Jun 8;49(6). doi: 10.1183/13993003.00546-2017. Print 2017 Jun.

Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease.

Eur Respir J. 2017 Jun 8;49(6). doi: 10.1183/13993003.01923-2016. Print 2017 Jun.

The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.

Turk J Gastroenterol. 2014 Dec;25 Suppl 1:63-8. doi: 10.5152/tjg.2014.6233.

Nonalcoholic fatty liver disease as a multi-systemic disease.

World J Gastroenterol. 2016 Apr 28;22(16):4079-90. doi: 10.3748/wjg.v22.i16.4079.

Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.

Nutr Metab Cardiovasc Dis. 2014 Jul;24(7):737-43. doi: 10.1016/j.numecd.2014.01.010. Epub 2014 Jan 29.

Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.

Dig Liver Dis. 2015 Mar;47(3):181-90. doi: 10.1016/j.dld.2014.09.020. Epub 2014 Nov 18.

Response to 'Effect of metabolic components on incident type 2 diabetes mellitus in nonalcoholic fatty liver disease subjects'.

Liver Int. 2016 Mar;36(3):462. doi: 10.1111/liv.12976.

Clinical importance of the nonalcoholic fatty liver disease: a review.

Probl Radiac Med Radiobiol. 2013(18):277-88.

Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.

Arab J Gastroenterol. 2014 Jun;15(2):76-81. doi: 10.1016/j.ajg.2014.05.002. Epub 2014 Jul 10.

Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Ceramides.

N Engl J Med. 2019 Nov 7;381(19):1866-1869. doi: 10.1056/NEJMcibr1910023.

引用本文的文献

Front Immunol. 2025 Feb 28;16:1514422. doi: 10.3389/fimmu.2025.1514422. eCollection 2025.

MAFLD associated with COPD via systemic inflammation independent of aging and smoking in men.

Diabetol Metab Syndr. 2022 Aug 16;14(1):115. doi: 10.1186/s13098-022-00887-w.

Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease.

J Clin Transl Hepatol. 2022 Apr 28;10(2):230-237. doi: 10.14218/JCTH.2021.00306. Epub 2022 Jan 4.

Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review.

Clin Mol Hepatol. 2022 Oct;28(4):725-738. doi: 10.3350/cmh.2022.0015. Epub 2022 Mar 14.

Exogenous Bioactive Peptides Have a Potential Therapeutic Role in Delaying Aging in Rodent Models.

Int J Mol Sci. 2022 Jan 26;23(3):1421. doi: 10.3390/ijms23031421.

Hepatic Fibrosis Assessed Using Fibrosis-4 Index Is Predictive of All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease.

Int J Chron Obstruct Pulmon Dis. 2020 Apr 17;15:831-839. doi: 10.2147/COPD.S242863. eCollection 2020.

[Anesthesiological aspects of liver transplantation].

Anaesthesist. 2019 Jun;68(6):403-418. doi: 10.1007/s00101-019-0595-x.

Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study.

PLoS One. 2019 Jan 23;14(1):e0208736. doi: 10.1371/journal.pone.0208736. eCollection 2019.

Relationship between obstructive lung disease and non-alcoholic fatty liver disease in the Korean population: Korea National Health and Nutrition Examination Survey, 2007-2010.

Int J Chron Obstruct Pulmon Dis. 2018 Aug 28;13:2603-2611. doi: 10.2147/COPD.S166902. eCollection 2018.

Nonalcoholic fatty liver disease: Evolving paradigms.

World J Gastroenterol. 2017 Sep 28;23(36):6571-6592. doi: 10.3748/wjg.v23.i36.6571.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献